Triamcinolone Acetonide Intravitreal Injection
Last Updated: April 27, 2020
- Triesence intravitreal suspension for injection, Novartis, 40 mg/mL, 1 mL vial, NDC 00065-0543-01
- Novartis has Triesence on shortage due to manufacturing delays.
- There are no presentations available
Estimated Resupply Dates
- Novartis has Triesence 40 mg/mL 1 mL vials on limited allocation.
Updated April 27, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 27, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.